Biogen Net Tangible Assets from 2010 to 2026

IDP Stock  EUR 161.35  1.55  0.95%   
Biogen's Net Tangible Assets are decreasing over the last several years with very volatile swings. Net Tangible Assets are predicted to flatten to about 3.1 B. Net Tangible Assets is the total assets of Biogen Inc minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2017-03-31
Previous Quarter
B
Current Value
5.8 B
Quarterly Volatility
1.2 B
 
Covid
 
Interest Hikes
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen's main balance sheet or income statement drivers, such as Interest Expense of 171.9 M, Selling General Administrative of 2.5 B or Total Revenue of 9.1 B, as well as many indicators such as . Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
  
This module can also supplement various Biogen Technical models . Check out the analysis of Biogen Correlation against competitors.
The Net Tangible Assets trend for Biogen Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Biogen is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Biogen's Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Biogen Inc over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Biogen's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Very volatile
   Net Tangible Assets   
       Timeline  

Biogen Net Tangible Assets Regression Statistics

Arithmetic Mean4,427,983,399
Geometric Mean4,244,518,826
Coefficient Of Variation26.61
Mean Deviation952,880,707
Median5,020,300,000
Standard Deviation1,178,265,208
Sample Variance1388308.9T
Range3.9B
R-Value(0.07)
Mean Square Error1473259.2T
R-Squared0.01
Significance0.78
Slope(16,719,553)
Total Sum of Squares22212942.4T

Biogen Net Tangible Assets History

20263.1 B
20255.2 B
20225.8 B
20212.9 B
20201.9 B
20194.1 B
20184.2 B

About Biogen Financial Statements

Biogen stakeholders use historical fundamental indicators, such as Biogen's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Biogen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biogen's assets and liabilities are reflected in the revenues and expenses on Biogen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biogen Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Tangible Assets5.2 B3.1 B

Currently Active Assets on Macroaxis

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out the analysis of Biogen Correlation against competitors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Biogen's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.